BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $226,000 | -6.2% | 1,497 | -9.6% | 0.00% | 0.0% |
Q2 2022 | $241,000 | -9.7% | 1,656 | -26.6% | 0.00% | 0.0% |
Q1 2022 | $267,000 | -14.7% | 2,256 | -0.7% | 0.00% | 0.0% |
Q4 2021 | $313,000 | +8.3% | 2,271 | +9.0% | 0.00% | 0.0% |
Q3 2021 | $289,000 | +36.3% | 2,083 | -4.4% | 0.00% | – |
Q2 2021 | $212,000 | -44.2% | 2,180 | -68.8% | 0.00% | -100.0% |
Q4 2019 | $380,000 | +31.9% | 6,979 | +1.2% | 0.00% | 0.0% |
Q3 2019 | $288,000 | -5.9% | 6,895 | -1.4% | 0.00% | 0.0% |
Q2 2019 | $306,000 | -22.7% | 6,995 | -9.1% | 0.00% | -50.0% |
Q1 2019 | $396,000 | +40.4% | 7,699 | +1.0% | 0.00% | +100.0% |
Q4 2018 | $282,000 | -1.4% | 7,624 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $286,000 | -1.7% | 7,624 | +3.4% | 0.00% | 0.0% |
Q2 2018 | $291,000 | – | 7,374 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |